Market News & Trends
VERAXA Biotech & Secarna Pharmaceuticals Initiate Antibody Oligonucleotide Conjugate Alliance in Immunology
VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. and Secarna Pharmaceuticals GmbH & Co. KG,…
Sharp Appoints Samantha Wilson Jones as General Counsel
Sharp Services, a leader in pharmaceutical packaging, clinical trial services & sterile manufacturing, has appointed Samantha Wilson Jones as General Counsel and Corporate Secretary of…
Faeth Therapeutics’ R&D Platform Delivers First Cross-Disease Validation Beyond Oncology
Faeth Therapeutics has launched a new R&D initiative aimed at preserving neurocognitive function in children with tyrosinemia type 1 (TT1), marking the expansion of its platform…
HCW Biologics Participates in Virtual Investor What This Means Segment About its Proprietary T-Cell Engager Program
HCW Biologics Inc. recently announced Peter Rhode, PhD, Chief Scientific Officer and Vice President of Clinical Operations of HCW Biologics, participated in a Virtual Investor…
Orexo US Awarded $8 Million by BARDA for OX390 Development Partnership
Orexo AB recently announced its wholly owned US subsidiary, Orexo US, Inc., has been awarded USD 8 million in funding by the Biomedical Advanced Research…
Credence MedSystems & SMC Ltd. Pharma Services Announce Collaboration to Advance Dual Chamber Fill-Finish Capabilities
Credence MedSystems, Inc. (Credence), an innovator in advanced injectable delivery systems that solve unmet market needs for the pharmaceutical industry, and SMC Ltd. Pharma Services…
Harrow to Acquire Melt Pharmaceuticals
Harrow recently announced it has entered into an agreement to acquire Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies for sedation for…
Gattefossé Inaugurates New Manufacturing Facility in Texas
Gattefossé, a leading provider of specialty ingredients and formulation solutions for personal care and pharmaceutical industries, celebrated the grand opening of its new manufacturing facility…
AIM ImmunoTech Secures Patent Through 2039 for Novel Cancer Therapy
AIM ImmunoTech Inc. recently announced the Japan Patent Office has issued a patent covering the Company’s proprietary use of Ampligen (Rintatolimod) in combination with checkpoint…
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated With Atebimetinib + mGnP
Immuneering Corporation recently announced positive updated survival and safety data from its ongoing Phase 2a trial of atebimetinib (IMM-1-104) in combination with modified gemcitabine/nab-paclitaxel (mGnP)…
Arecor Announces Co-Development Agreement With US Insulin Pump Device Company
Arecor Therapeutics plc has recently signed a co-development agreement with Sequel Med Tech LLC, a company developing state-of-the-art insulin delivery technologies, to combine AT278 (500U/mL)…
Hovione & Microinnova Partner to Advance Modular Flow Chemistry for Multi-Purpose Manufacturing
Hovione recently announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry. The companies will work together to test Microinnova’s…
Mstack Launches Chemstack AI - A Revolutionary AI-led R&D Platform
As rising tariffs and shifting geopolitical dynamics drive unprecedented demand for domestic chemical supply chains, a fundamental bottleneck has emerged: the specialized process chemistry knowledge…
eXmoor Pharma & Siam Bioscience Form Strategic Partnership to Establish Leading Cell & Gene Therapy Services
eXmoor Pharma and Siam Bioscience recently announced a strategic partnership to build the region’s foremost centre for Cell and Gene Therapy (CGT) development and manufacturing.…
Yatiri Bio Receives Grant to Advance Proteomics Interoperability in Cancer Research
Yatiri Bio Inc. recently announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability, aimed at improving how…
Nanexa Receives Japanese Patent Approval for Specific PharmaShell Structure
Nanexa recently announced a key patent application has been granted in Japan and has been given the patent number JP7733651B2. The patented invention concerns a…
Abzena Enhances AbZelectPRO Cell Line Offering With New GS Knockout Platforms
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, announced the expansion of its AbZelectPRO cell line development (CLD) platform with the launch…
Evonik Launches MaxiPure Polysorbate 80 for Injectable Drug Formulations
Evonik has launched MaxiPure Polysorbate 80 – a highly pure surfactant designed for injectable and biopharmaceutical applications. Engineered to meet the stringent demands of modern…
Kensana Health Lands $120 Million From GEM, Fueling a Global Plant Based Medicine Revolution
Kensana Health Inc. recently announced it has entered into a share subscription facility of up to $120 million with GEM Global Yield LLC SCS, a…
Esperion Partner Otsuka Receives Regulatory Approval to Market NEXLETOL for the Treatment of Hypercholesterolemia
Esperion recently announced Otsuka Pharmaceutical Co., Ltd., the Company’s partner for the development and commercialization of NEXLETOL (bempedoic acid) tablets in Japan, has received approval…
